Cannabics Pharmaceuticals Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$36.3 M |
Shares Outstanding |
134.46 M |
Public Float |
43.65 M |
Address |
No. 3 Bethesda Metro Center Bethesda Maryland 20814 United States |
Employees | - |
Website | http://www.cannabics.com |
Updated | 07/08/2019 |
Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD. |